Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Assets (2019 - 2025)

Historic Assets for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $88.7 million.

  • Biodesix's Assets fell 1364.67% to $88.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.7 million, marking a year-over-year decrease of 1364.67%. This contributed to the annual value of $97.2 million for FY2024, which is 186.89% down from last year.
  • Biodesix's Assets amounted to $88.7 million in Q3 2025, which was down 1364.67% from $87.7 million recorded in Q2 2025.
  • Biodesix's Assets' 5-year high stood at $115.8 million during Q2 2024, with a 5-year trough of $61.7 million in Q1 2022.
  • For the 5-year period, Biodesix's Assets averaged around $88.8 million, with its median value being $87.7 million (2025).
  • Its Assets has fluctuated over the past 5 years, first skyrocketed by 9334.65% in 2021, then crashed by 4661.6% in 2022.
  • Quarter analysis of 5 years shows Biodesix's Assets stood at $76.1 million in 2021, then grew by 22.09% to $92.9 million in 2022, then rose by 6.66% to $99.1 million in 2023, then decreased by 1.87% to $97.2 million in 2024, then fell by 8.76% to $88.7 million in 2025.
  • Its Assets stands at $88.7 million for Q3 2025, versus $87.7 million for Q2 2025 and $86.2 million for Q1 2025.